Fisher & Paykel Healthcare Corporation Limited (ASX: FPH)
27.05
-0.20 (-0.73%)
Jul 3, 2024, 4:10 PM AEST
FPH Revenue
In the fiscal year ending March 31, 2024, Fisher & Paykel Healthcare Corporation had annual revenue of 1.76B NZD with 18.24% growth.
Revenue
1.76B NZD
Revenue Growth
+18.24%
P/S Ratio
9.87
Revenue / Employee
251,949 NZD
Employees
6,978
Market Cap
15.80B AUD
Revenue Chart
* This company reports financials in NZD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 1.76B | 271.21M | 18.24% |
Mar 31, 2023 | 1.49B | -34.41M | -2.26% |
Mar 31, 2022 | 1.52B | -270.10M | -15.08% |
Mar 31, 2021 | 1.79B | 557.95M | 45.24% |
Mar 31, 2020 | 1.23B | 204.14M | 19.83% |
Mar 31, 2019 | 1.03B | 122.22M | 13.47% |
Mar 31, 2018 | 907.09M | 110.30M | 13.84% |
Mar 31, 2017 | 796.79M | 58.04M | 7.86% |
Mar 31, 2016 | 738.75M | 94.73M | 14.71% |
Mar 31, 2015 | 644.01M | 75.41M | 13.26% |
Mar 31, 2014 | 568.60M | 61.35M | 12.10% |
Mar 31, 2013 | 507.25M | 40.52M | 8.68% |
Mar 31, 2012 | 466.73M | -954.00K | -0.20% |
Mar 31, 2011 | 467.68M | -7.08M | -1.49% |
Mar 31, 2010 | 474.76M | -10.76M | -2.22% |
Mar 31, 2009 | 485.52M | 139.55M | 40.34% |
Mar 31, 2008 | 345.97M | -3.28M | -0.94% |
Mar 31, 2007 | 349.24M | 59.70M | 20.62% |
Mar 31, 2006 | 289.55M | 48.41M | 20.08% |
Mar 31, 2005 | 241.14M | 26.27M | 12.23% |
Mar 31, 2004 | 214.87M | 6.45M | 3.09% |
Mar 31, 2003 | 208.42M | -4.83M | -2.27% |
Mar 31, 2002 | 213.25M | 20.41M | 10.58% |
Mar 31, 2001 | 192.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
CSL Limited | 31.72B |
ResMed Inc. | 6.63B |
Cochlear Limited | 2.18B |
Pro Medicus Limited | 142.12M |
Sonic Healthcare Limited | 8.21B |
Ramsay Health Care Limited | 15.96B |
Telix Pharmaceuticals Limited | 502.55M |
Neuren Pharmaceuticals Limited | 231.93M |
Fisher & Paykel Healthcare Corporation News
- 5 weeks ago - Fisher & Paykel leaves pandemic behind as respirator demand grows - The Australian Financial Review
- 5 weeks ago - Full Year 2024 Fisher & Paykel Healthcare Corporation Ltd Earnings Call Transcript - GuruFocus
- 5 weeks ago - Fisher & Paykel Healthcare Corporation Limited 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 5 weeks ago - Fisher & Paykel Healthcare Corporation Limited (FSPKF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Property Insider: Who leased billionaire Graeme Hart’s new properties; Fletcher changes unprecedented; Fisher & Paykel Appliances advances $220m plans - NZ Herald
- 4 months ago - This fundie says Domino’s Pizza is a better bet than the big four - The Australian Financial Review
- 4 months ago - New Zealand’s Largest Companies by market capitalization, 2024 - CEOWORLD magazine
- 7 months ago - Fisher & Paykel Healthcare Corp Ltd's Dividend Analysis - GuruFocus